Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study.
Béatrice M F WinkelEmma SchramHendrik GremmelsSylvia DebastRob SchuurmanAnnemarie WensingMarc BontenEdwin GoedhartMarije Hofstranull nullPublished in: BMJ open (2021)
The Panbio COVID-19 Ag rapid test identifies 81%-90% of presymptomatic and early asymptomatic SARS-CoV-2 infections with high specificity. This test may therefore be adopted in testing strategies such as targeted screening of specific populations where prevalence is low.